Objectives: To assess the frequency of adverse effects among pediatric and adult patients
and the clinical variables associated with a higher probability of developing side effects …

Objectives Vagus nerve stimulation (VNS) is an accepted treatment for medically intractable
epilepsy. However, predictive factors associated with responsiveness to VNS remained …

Objective: This retrospective study documented long-term outcome of patients receiving
vagus nerve stimulation (VNS) therapy for pharmacoresistant epilepsy. Methods: Medical …

Introduction Vagus nerve stimulation (VNS) has been used as an adjunctive therapy for both
children and adults with refractory epilepsy, over the last two decades. In this study, we …

Objective To evaluate the efficacy of vagus nerve stimulation (VNS) in pediatric patients with
medically refractory epilepsy. Method We reviewed the medical records of 252 consecutive …

Vagus nerve stimulation (VNS) is an alternative treatment for medically or surgically
refractory epilepsy. The long-term efficacy and safety of VNS were evaluated in a large …

Vagus nerve stimulation (VNS) is approved by FDA for treatment of intractable epilepsy in
children over 12 years of age. We assessed the efficacy of VNS therapy in younger children …

Objective To gain insight into the long‐term impact of vagus nerve stimulation (with VNS
Therapy) in children with drug‐resistant epilepsy, we conducted the largest retrospective …

Background: The management of intractable epilepsy in children and adults is challenging.
For patients who do not respond to anti-epileptic drugs and are not suitable candidates for …

Background: Vagus nerve stimulation (VNS) therapy has been widely recognized as an
alternative for the treatment of drug-resistant epilepsy, although modification of antiepileptic …